Absorption: Absorption from tablet is variable; may be better with oral liquid formulations. Well absorbed after IM administration.
Distribution: Widely distributed, high concentrations in the CNS. Crosses the placenta and probably enters breast milk.
Protein Binding: 90%.
Metabolism/Excretion: Highly metabolized by the liver and GI mucosa. Converted to some compounds with antipsychotic activity.
Half-life: Unknown.
Contraindicated in:
Use Cautiously in:
EENT: blurred vision, dry eyes, lens opacities.
CV: ECG changes, hypotension, tachycardia.
GI: constipation, dry mouth, anorexia, drug-induced hepatitis, ileus.
GU: pink or reddish-brown discoloration of urine, urinary retention.
Derm: photosensitivity, pigment changes, rashes.
Endo: galactorrhea.
Hemat: AGRANULOCYTOSIS, leukopenia.
Metab: hyperthermia.
Neuro: NEUROLEPTIC MALIGNANT SYNDROME, extrapyramidal reactions, sedation, tardive dyskinesia.
Misc: allergic reactions.
Drug-Drug:
Drug-Natural Products:
Antiemetic
Antipsychotic
Antianxiety
IV Administration:
Compazine, Compro
(Generic available)
(antiemetic effect)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | 3040 min | unknown | 34 hr |
Rect | 60 min | unknown | 34 hr |
IM | 1020 min | 1030 min | 34 hr |
IV | rapid (min) | 1030 min | 34 hr |
NDC Code*